- Home
- EDIT vs PAMT Comparison
EDIT vs PAMT Comparison
Compare EDIT & PAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- PAMT
- Stock Information
- Founded
- EDIT 2013
- PAMT 1980
- Country
- EDIT United States
- PAMT United States
- Employees
- EDIT N/A
- PAMT N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- PAMT Trucking Freight/Courier Services
- Sector
- EDIT Health Care
- PAMT Industrials
- Exchange
- EDIT Nasdaq
- PAMT Nasdaq
- Market Cap
- EDIT 269.8M
- PAMT 223.5M
- IPO Year
- EDIT 2016
- PAMT 1985
- Fundamental
- Price
- EDIT $2.40
- PAMT $8.98
- Analyst Decision
- EDIT Buy
- PAMT Hold
- Analyst Count
- EDIT 10
- PAMT 1
- Target Price
- EDIT $4.13
- PAMT $13.00
- AVG Volume (30 Days)
- EDIT 2.0M
- PAMT 10.7K
- Earning Date
- EDIT 11-10-2025
- PAMT 10-28-2025
- Dividend Yield
- EDIT N/A
- PAMT N/A
- EPS Growth
- EDIT N/A
- PAMT N/A
- EPS
- EDIT N/A
- PAMT N/A
- Revenue
- EDIT $46,383,000.00
- PAMT $623,270,000.00
- Revenue This Year
- EDIT N/A
- PAMT N/A
- Revenue Next Year
- EDIT N/A
- PAMT $12.19
- P/E Ratio
- EDIT N/A
- PAMT N/A
- Revenue Growth
- EDIT N/A
- PAMT N/A
- 52 Week Low
- EDIT $0.91
- PAMT $8.91
- 52 Week High
- EDIT $4.54
- PAMT $20.65
- Technical
- Relative Strength Index (RSI)
- EDIT 34.46
- PAMT 34.48
- Support Level
- EDIT $2.30
- PAMT $8.91
- Resistance Level
- EDIT $2.55
- PAMT $10.40
- Average True Range (ATR)
- EDIT 0.20
- PAMT 0.52
- MACD
- EDIT -0.00
- PAMT -0.10
- Stochastic Oscillator
- EDIT 20.00
- PAMT 4.20
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About PAMT PAMT CORP Common Stock
PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.